PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.95%
Revenue growth under 50% of 3391.T's 21.55%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.35%
Gross profit growth under 50% of 3391.T's 17.84%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.69%
Negative EBIT growth while 3391.T is at 10.45%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.56%
Negative operating income growth while 3391.T is at 13.49%. Joel Greenblatt would press for urgent turnaround measures.
4.01%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
4.00%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
4.00%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3391.T is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.70%
10Y revenue/share CAGR under 50% of 3391.T's 73.89%. Michael Burry would suspect a lasting competitive disadvantage.
2.70%
5Y revenue/share CAGR under 50% of 3391.T's 73.89%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.41%
Negative 3Y CAGR while 3391.T stands at 54.90%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 3391.T is at 100.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
7.58%
Below 50% of 3391.T's 213.55%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
7.58%
Below 50% of 3391.T's 213.55%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-26.90%
Negative 3Y CAGR while 3391.T is 194.55%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
36.05%
Below 50% of 3391.T's 72.53%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
36.05%
Below 50% of 3391.T's 72.53%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-8.39%
Negative 3Y equity/share growth while 3391.T is at 46.70%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.29%
Negative near-term dividend growth while 3391.T invests at 180052.35%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
25112.50%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.54%
We show growth while 3391.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
10.94%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.72%
BV/share growth above 1.5x 3391.T's 2.80%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
116.68%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-31.48%
We cut SG&A while 3391.T invests at 20.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.